Yüklüyor......
Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) can lead to non-alcoholic steato-hepatitis (NASH) and cirrhosis. Fibrosis predicts worse outcomes and mortality. New treatments targeting fibrosis are being investigated to reverse disease progression. AIM: To review the new pipeline therapeutic...
Kaydedildi:
| Yayımlandı: | Aliment Pharmacol Ther |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5906100/ https://ncbi.nlm.nih.gov/pubmed/27061197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.13620 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|